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ABSTRACT
We describe a new, broadly applicable methodology
for screening in parallel interactions of RNA-binding
proteins (RBPs) with large numbers of microRNA
(miRNA) precursors and for determining their
affinities in native form in the presence of cellular
factors. The assays aim at identifying pre-miRNAs
that are potentially affected by the selected RBP
during their biogenesis. The assays are carried out
in microtiter plates and use chemiluminescent
readouts. Detection of bound RBPs is achieved
by protein or tag-specific antibodies allowing
crude cell lysates to be used as a source of RBP.
We selected 70 pre-miRNAs with phylogenetically
conserved loop regions and 25 precursors of other
well-characterized miRNAs for chemical synthesis
in 30-biotinylated form. An equivalent set in unmodi-
fied form served as inhibitors in affinity determin-
ations. By testing three RBPs known to regulate
miRNA biogenesis on this set of pre-miRNAs, we
demonstrate that Lin28 and hnRNP A1 from cell
lysates or as recombinant protein domains recog-
nize preferentially precursors of the let-7 family,
and that KSRP binds strongly to pre-miR-1-2.
INTRODUCTION
In the past years, several reports have highlighted the
roles of individual RNA-binding proteins (RBP) in the
regulation of microRNA (miRNA) biogenesis (reviewed
in 1–3). The stem-loop structures of miRNA precursors
exhibit many characteristic features that are recognized
by RBPs. Examples of such features are the two-nucleotide
(nt) overhangs at the 30-ends for PAZ domain containing
RBPs and the double-stranded regions in the stem of
primary-miRNAs (pri-miRNAs) for nuclear factor 90 (4).
Exportin 5 requires the entire stem and the 30-overhangs to
bind and exert its function (5). A further important element
offering binding sites for RBPs and opportunities for
control of processing are the terminal loop regions of
miRNA precursors, which vary in length between 14 and
40 nts. Although short terminal loop regions can form
stable structures, the longer loops may have properties
akin to those of single-stranded RNAs. One of the best
characterized examples is the let-7 family that bears large
loop regions. These contain short conserved motifs that
allow Lin28 and other RBPs to bind and regulate let-7
biogenesis (6–11). Interestingly, for a sizable fraction of
miRNA precursors, terminal loop regions are highly
conserved (12) presumably to enable control of miRNA
precursor processing by cognate RBPs. This regulation
can be stimulatory or inhibitory, it can involve individual
or subsets of miRNAs and it can be nuclear or cytoplasmic
(13). Many of these RBPs have been known previously for
different functions such as splicing and regulation of
mRNA stability. Thus, hnRNP A1 enhances Drosha
cleavage of pri-mir-18a (12,14), but it retards processing
of pri-let-7a-1 (15). KSRP, a mediator of mRNA decay,
binds miRNA terminal loops and enhances Drosha as well
as Dicer processing (16). The splicing factor SF2/ASF has
been shown to affect the expression of 40 miRNAs (17),
and RBM3, a cold inducible RBP, affects Dicer processing
of a majority of miRNAs (18), whereas the hnRNP-like
TDP-43 promotes Dicer and Drosha processing (19).
These examples paint a picture of widespread control of
miRNA activity via RBP-mediated regulation of their
precursors.
To expound this area, new methods are needed to
identify the interaction of RBPs with pri- or pre-
miRNAs, to deﬁne their binding sites and afﬁnities. We
therefore elaborated a strategy of testing RBP binding
in vitro as a predictor for potential effects in vivo. Here,
we demonstrate a directed approach for testing pre-
selected RBPs for binding to large numbers of synthetic
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miRNA precursors in parallel. We chemically synthesized
a unique set of pre-miRNAs with highly conserved
terminal loop regions (12) that are, owing to their biogen-
esis, also present on primary transcripts. For the assays,
we chose a sensitive chemiluminescent system on
microtiter plates that allowed detection of either the
RNA or the protein component. We illustrate the poten-
tial of these assays to reveal and characterize both known
and new interactions between 95 pre-miRNAs and three
RBPs, Lin28, hnRNP A1 and KSRP, in native form and
in the presence of cellular factors. These RBPs have been
previously shown to bind to miRNA precursors. We show
that Lin28 and hnRNP A1 select pre-let-7 family members
with remarkable preference within our set of pre-miRNAs
and determine the afﬁnities of selected pre-miRNAs
to hnRNP A1 by competition versions of these assays.
For KSRP, we ﬁnd that this protein binds prominently
to pre-miR-1-2. The results suggest that the approach
of screening for direct binding between RBPs and pre-
miRNAs in vitro has the potential of identifying inter-
actions that affect miRNA biogenesis.
MATERIALS AND METHODS
Synthesis of pre-miRNAs
Pre-miR sequences were extracted from information
provided in reference (20) and the miRBase database (21)
(http://www.mirbase.org/). The assembly of pre-miRNAs
was carried out in 96-well plate format on a Dr. Oligo
synthesizer (Biolytics Lab Performance, Inc.) from
controlled pore glass (CPG) solid support (1000 A˚ with a
typical loading of 35 mmol/g) and 20-O-[(triiso-
propylsilyl)oxy]methyl (TOM)-protected ribonucleoside
phosphoramidites. Biotin modiﬁcations at the 30-end of
the sequences were introduced by using Biotin Serinol
CPG (Glen Research). For sequence assembly, a
standard coupling cycle was used using 4% dichloroacetic
acid in dichloromethane for the detritylation steps, 0.07M
amidite and 0.25M ethylthiotetrazole in acetonitrile for the
coupling steps, a 1:1 mixture of 20%N-methylimidazole in
tetrahydrofuran and acetic acid anhydride/pyridine/tetra-
hydrofuran (8:1:1) for the capping steps and 0.01M iodine
in pyridine/water/acetonitrile (3:15:32) for the oxidation
steps. All pre-miRNAs were produced conserving the
dimethoxytrityl group at the 50-end of the sequence.
Deprotection and cleavage from the solid support were
carried out in the gas phase in a pressure-proof vessel
using gaseous monomethylamine for 60min at 27 psi and
70C. After gas phase deprotection, the RNA sequences
were recovered from the solid support by treatment with
triethylamine trihydroﬂuoride in dimethylsulfoxide/
1-methyl-2-pyrrolidone/triethylamine (11:4:5), and
deprotection of the 20-O-TOM-protecting group was
completed by heating the resulting solution at 65C for
2 h. The reaction was quenched by diluting the depro-
tection solution with 1M aqueous triethylammonium
acetate. Puriﬁcation was carried out on DNA Top-10 cart-
ridges (Varian, Inc.). Cartridges were conditioned with
acetonitrile followed by 1M aqueous triethylammonium
acetate. Subsequently, the deprotection solution
containing the RNA sequences was applied onto the cart-
ridges followed by treatment with a 3:2 mixture of 100 g/L
aqueous sodium chloride and methanol. The 50-
dimethoxytrityl group of the full length product was
removed by treating the column with aqueous 2%
triﬂuoroacetic acid followed by extensive washing with
water. The full-length product was recovered from the cart-
ridge by eluting with 50mM tetraethylammonium carbon-
ate in acetonitrile/water (1:1). Sequences were quantiﬁed by
ultraviolet absorption measurements, adjusted to a yield of
10 nmol per well and dried down.
Synthesis of oligoribonucleotides
The hnRNP A1 ‘winner’ sequences (22) 50-UAUGAUAG
GGACUUAGGGUG-30 and a biotinylated version, 50-UA
UGAUAGGGACUUAGGGUGTTT-biotin-30, were
synthesized on a MerMade 12 instrument (Bioautomation
Corporation, Plano, USA) under standard conditions.
UnySupport CPG and 30-BiotinTEG-CPG were obtained
fromGlenResearch (Sterling, USA) and phosphoramidites
from Thermo Fisher ScientiEc (Milwaukee, USA). RNAs
were deprotected with gaseous monomethylamine (65C
at 1 bar pressure for 2 h). RNAs were eluted with EtOH/
water (1:1).Desilylationwas carried out on dryRNAsusing
freshly prepared 1-methyl-2-pyrrolidone, triethylamine
(TEA) and TEA.3HF (6:3:4) for 90min at 70C.
Isopropoxytrimethylsilane was added, and samples were
lyophilized. The crude RNA was subjected to HPLC
(Agilent 1200 Series; Agilent Technologies, Santa Clara,
USA). Dimethoxytrityl groups were cleaved using 40%
acetic acid for 30min at RT. RNAs were again puriEed
by HPLC using a C18 column (XBridge OST, particle size
2.5 mm; Waters, Milford, USA). Puriﬁed samples were
analysed on an Agilent 6130 Series Quadrupole LC/MS
(Agilent Technologies, Santa Clara, USA) with electron
spray ionization. Purity and yields were determined by
HPLC and Nanodrop, respectively.
Screening with directly coated recombinant proteins
White microtiter plates (96- or 384-well type, NUNC,
Maxisorp) were used in all plate assays. The volumes for
the 96-well format were 50 ml, and for the 384-well format,
20 ml. All washing steps were done 3–8 times with running
deionized water, which allowed rapid and thorough
washing. Coating with Lin28 zinc ﬁnger (ZnF) domain
was carried out overnight at 5 mg/ml in 10mM Hepes pH
7.2, 100mM KCl, 0.5mM DTT, 1 mM ZnCl2. The plate
was emptied and left in blocking buffer (coating buffer sup-
plemented with10 mg/ml heparin, 0.05% Tween 20, 0.1mM
DTT) for 1 h. Following a washing step with water,
biotinylated pre-miRNAs were added at a concentration
of 5 nM in blocking buffer for 2 h at 4C. The plate was
emptied (without washing) and exposed to a formaldehyde
solution [0.5% in phosphate buffered saline (PBS)] for
5min. This step was intended to prevent dissociation of
the RNA from the RBP during subsequent steps.
Formaldehyde is known to crosslink RNA to proteins
(23) and to denature RNA, a capacity exploited in
denaturing gel electrophoresis (24). In our experiments,
the ﬁxation step stabilized the interaction and was
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retained in all of our microtiter plate experiments. In the
case of Lin28, signals increased by 50% by this measure.
The ﬁxation step may not always be necessary as
demonstrated in an assay that also used directly adsorbed
proteins (25). For hnRNP A1 (UP1), the coating buffer
was PBS, and the blocking and binding buffer composed
of 25mMHepes, 300mMNaCl, 0.05% Tween 20, 0.5mM
TCEP [tris(2-carboxyethyl)phosphine hydrochloride,
neutralized, Pierce, Cat. no. 77720] and 1% Top-Block (a
derivative of gelatin, LuBioScience, Lucerne, Switzerland).
Bound biotinylated RNA was detected by a peroxidase
conjugate of streptavidin (Sigma, 0.1 mg/ml in 150mM
NaCl, 25mM Hepes pH 7.2, 0.05% Tween 20, 1%
Top-Block). The plate was again washed, and BM chemi-
luminescent substrate (Roche Applied Science, Cat. no. 11
582 950 001) was added. Plates were sealed with a transpar-
ent foil before measurement (26) in a luminometer (Mithras
940, Berthold, Regensdorf, Switzerland). For presentation
of the data, we subtracted a general background corres-
ponding to the average of the 5th or 10th percentiles
and re-scaled the signals by dividing by the maximal
values in the assay. This transformation does not change
the overall shape of the bar graph. The background in wells
without protein coating was 2000–3000 counts/s, whereas
signals reached up to 5 000 000 counts/s.
Screening immobilized biotinylated pre-miRNAs with
cell lysates
Plates were coated with streptavidin (Sigma, Cat. no.
85878 or S4762) at 2 mg/ml in PBS for 16 h or longer at
4C and blocked with 150mM NaCl, 25mM Hepes pH
7.2, 0.05% Tween 20, 1% Top-Block. Biotinylated
oligoribonucleotides were diluted to 4–10 nM in 25mM
Hepes pH 7.2 and allowed to bind for 3 h at room tem-
perature or overnight at 4C. The wells were washed with
cold water and cell lysates (diluted from frozen aliquots
into a buffer of 300mM NaCl, 25mM Hepes pH 7.2,
0.05% Tween 20, 1% Top-Block, 0.5mM TCEP, for
Lin28 additionally 10mM ZnCl2) added for 1 h at 4C, a
temperature chosen to reduce potential RNAse activity in
the cell lysate. We noticed that lysates stored for pro-
longed periods even at 80C showed reduced activity,
particularly for Lin28. Lysate dilutions were 100 times
for Lin28 and hnRNP A1 experiments, and 20 times for
KSRP. The plate was emptied and ﬁxed with formalde-
hyde as described earlier in the text. The bound protein of
interest was detected with antibodies against Myc (clone
9E10, Santa Cruz) or anti-hnRNP A1 [clone 4B10, Santa
Cruz, Cat. no. sc-32301, originally described in reference
(27)]; it does not recognize hnRNP A2 or hnRNP B
proteins, both at 0.1mg/ml for 1 h at room temperature.
Anti-KSRP (Bethyl Laboratories, LuBioScience, Cat. no.
A302-021A) was used at 0.1mg/mL with a 3 h incubation
at 4C. The results of western blots analysis carried out
with these antibodies on Hela cell extracts were in agree-
ment with the expected molecular weights for hnRNP A1
and KSRP (cf. Supplementary Figure S1). The buffer for
primary and secondary peroxidase conjugated antibodies
was 150mM NaCl, 25mM Hepes pH 7.2, 0.05% Tween
20, 1% Top-Block. The peroxidase conjugates against
mouse and rabbit IgG (Cat. no. 074-1806 and 074-1506,
respectively, KPL, BioConcept AG, Allschwil,
Switzerland) were applied at a dilution of 1/3000 for 1 h.
As mentioned earlier, a chemiluminescent substrate was
used for signal generation. Examples of lysate dilution
curves are presented in Supplementary Figure S2.
Determination of afﬁnities by ELISA inhibition assays
For determining binding afﬁnities, a two-step assay was
used. Varying concentrations of the oligoribonucleotides
to be tested were incubated with a constant dilution
(1/100) of Hela cell lysate in a buffer containing 250mM
NaCl, 25mM Hepes pH 7.2, 0.5mM TCEP, 0.05%
Tween 20 and 1% Top-Block. These mixtures, prepared
in polypropylene 96-well plates (NUNC, Cat.
no. 732-2620), were kept at 4C for 3 h and, in the cold
room, 20 ml aliquots transferred to white 384-well
microtiter plates that had been coated for 4 h with 20 ml
of 5 nM solution of a biotinylated oligoribonucleotide
known to bind hnRNP A1 (UAUGAUAGGGACUUA
GGGUGTTT-biotin, corresponding to the ‘winner’
sequence extended with three thymidine residues and
biotin). The plate was washed with cold water to
minimize temperature-dependent edge effects. After
30min incubation at 4C, the plate was emptied (without
washing), ﬁxed and processed as described earlier for the
cell lysate screening assay with immobilized biotinylated
pre-miRNAs. The data were ﬁtted to a logistic equation
(Y=(Bo-BG)/(1+([competitor]/IC50)
sl)+BG) using the
Solver feature of Excel: Y was the measured chemilumin-
escence and taken as proportional to the free fraction in the
pre-equilibration mixture, Bo corresponded to the signals
without inhibitor, BG was a constant background (1.3% of
the maximal signals) and IC50 and sl (slope) the parameters
to be determined. The Z0-factor (28) was 0.85.
Recombinant proteins
His6-tagged Lin28 ZnF (29) was used in the assay.
Myc-tagged Lin28 was prepared as described (29),
except that HEK293T cells were used as recipients of the
Myc-Lin28 encoding plasmid. Recombinant UP1 was
puriﬁed from Escherichia coli and consisted of residues
2-196 from hnRNPA1 (Uniprot P09651). Puriﬁcation
was performed by Ni-NTA chromatography of an
N-terminal His6-tagged UP1 followed by the cleavage of
the His6-tag by TEV protease resulting in a protein with
two additional glycine residues at the N-terminus before
the UP1 sequence (Dr. Pierre Barraud, ETH Zurich,
manuscript in preparation).
Cell culture, transfections and preparation of cell lysates
Hela (ATCC No. CCL-2, LGC, Molsheim, FR) and
HEK293T (CRL-11268, LGC, Molsheim, FR) cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium (Gibco)
containing 10% fetal bovine serum (Sigma).
Lysates of Hela cells for inhibition experiments were
prepared by washing cells with PBS and collecting with
a cell scraper. Following centrifugation, the cell pellet
(100ml) was suspended in 1ml Hepes pH 7.2, 200mM
NaCl, supplemented with a protease inhibitor mix
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(Complete Cat. no. 11836153001, Roche Diagnostics,
Switzerland, AG). The suspension was sonicated and
centrifuged at 14 000 rpm in an Eppendorf centrifuge for
10min. Glycerol (200ml) was added, and aliquots were
frozen in liquid nitrogen followed by storage at 80C.
MiRNA precursors associated with hnRNP A1
Immunoprecipitation was carried out for three independent
biological replicates with anti-hnRNP A1 mAb (Santa Cruz
4B10) or mouse serum IgG (Sigma, I5381) as negative
control. Lysates of PBS-washed Hela cells were obtained
by lysis of one conﬂuent T-75 ﬂask in 1ml of a buffer of
50mM HEPES, pH 7.5, 150mM KCl, 1% NP40, 0.5mM
DTT, 0.1% SDS, 2mM EDTA, complete protease inhibi-
tor EDTA-free (Roche), 50U/mL RNasin (Promega).
Antibodies were adsorbed to magnetic beads (Dyna-
beads Protein G, Invitrogen, 100-03D), according to
manufacturer’s instructions (10mg antibody/0.6mg beads).
The lysates were incubated with the 0.6mg beads at 4C for
1h (5mg total protein, ﬁnal volume 500ml equivalent to
10mg/ml). The beads were washed ﬁve times with 50mM
HEPES, pH 7.5; 150mM KCl; 0.05% IGEPAL, 0.5mM
DTT, 1 protease inhibitor mix (Roche Applied Biosys-
tems). Residual traces of DNA were subjected to on-bead-
digestion with RNAse free recombinant DNAse (Roche
Applied Biosystems) for 15min at room temperature, ac-
cording to manufacturer’s instructions. For RNA extrac-
tion, the beads were incubated in 200ml ﬁnal volume
containing 200mg recombinant proteinase K (Roche
Applied Biosystems) in digestion buffer (100mM Tris/HCl
pH 7.5, 150mM NaCl, 12.5mM EDTA, 2% SDS) for
15min at 65C with shaking followed by chloroform–
phenol extraction. RNA was reverse transcribed (high
capacity cDNA reverse transcription kit, Life Tech) using
random hexamer primers. Quantitative reverse transcriptase
polymerase chain reaction (PCR) (qRT-PCR) was per-
formed with FastStart Universal SYBR Green Master
(Rox) (Roche Applied Biosystems), according to supplier’s
instructions. The primers used are listed in Supplementary
Table S2. Approximately 50% of hnRNPA1 was captured
from the extract after incubation with antibody coated
beads, as assessed by western blot comparison of equivalent
amounts (5%) of bead supernatants, eluates and total lysate.
RESULTS
Components of the screening assay
For our screening assays and as tools for further charac-
terization, we chemically synthesized a set of 95 miRNA
precursors in 30-biotinylated and unmodiﬁed forms. The
length of human pre-miRNAs typically spans 50–90 nt
and likely represents the limit of solid-phase RNA synthe-
sis using readily available reagents. An example of state-
of-the-art chemical RNA synthesis is described in the
recent account of the synthesis of a 110-nt putative
precursor RNA using a specially developed
phosphoramidite (30). We used the 20-O-TOM
phosphoramidite, which is reportedly especially effective
for solid-phase synthesis of long RNAs (31). Sequences
selected were for the most part pre-miRNAs with
phylogenetically conserved terminal loop regions as
measured by the ratio of conservation scores between
loop and stem regions (12), and the remainder
well-characterized miRNAs expressed in cancer cell lines
(Supplementary Table S1).
In our approach, we probed selected RBPs for binding
to this set of oligoribonucleotides and used two sources of
protein in the screens: recombinant puriﬁed protein in
truncated forms that retain one or more RNA-binding
domains and, as a second source, crude cellular lysates.
During the course of our experiments and depending on
the availability of detection reagents, we devised several
assay conﬁgurations that are depicted and explained in the
schematics and legend of Figure 1. Essentially, in the
simplest conﬁguration, we directly coated recombinant
puriﬁed RBP to microtiter wells and probed with
biotinylated pre-miRNA. As an alternative, we allowed
RBPs to bind to immobilized biotinylated pre-miRNAs.
In this case, detection of the bound protein was achieved
by protein or tag-speciﬁc antibodies. A third, related assay
type served to derive afﬁnities by inhibition with un-
labelled pre-miRNAs.
Pre-let-7 family members are preferred targets of Lin28
and hnRNP A1
Lin28 is a small cytoplasmic RBP expressed during embry-
onic development. It contains an N-terminal cold shock
domain (CSD) and two CCHC-type ZnF domains, all
of which contribute in binding to let-7 precursors (32).
The recently solved NMR structure of human Lin28 ZnF
domain complexed to AGGAGAU has shown selective
recognition of the pre-let-7 family members by a
NGNNG consensus motif (29). We compared the
binding of native Lin28 with that of the Lin28 ZnF
domain, which had been used earlier to probe a small
subset of this library (29) and is shown here for the full
set of 95 pre-miRNAs. We adsorbed puriﬁed Lin28 ZnF
domain to microtiter wells and allowed it to capture
biotinylated pre-miRNAs (Figure 2A). A streptavidin-
peroxidase system generated the ﬁnal luminescent signals.
The strong preference of Lin28 for let-7 family precursors
was reinforced, though a few additional and reproducibly
high-scoring precursors (miR-181 members, pre-miR-9-1)
were observed. Using a reversed conﬁguration of the assay,
we then interrogated pre-bound biotinylated miRNA
precursors with a lysate of cells that expressed plasmid-
encoded Myc-tagged full-length Lin28 and used a tag-
speciﬁc antibody to measure bound Lin28 (Figure 2B).
Titrations of the cell lysates showed that dilutions in the
range of 50-fold were suitable for this type of assay
(Supplementary Figure S2A). Gratifyingly, the same
binding events observed with the ZnF domain were
present in the new proﬁle, which again highlighted the
let-7 family, miR-9-1 and miR-181 members but also con-
tained an array of additional signals. These may have
originated from the CSD or from other RBPs in the
lysate that mediated Lin28 binding. Some of the signals
may represent transient, non-functional contacts between
the RBP and the RNA, at the terminal loop or other parts
of the structure. Of note, both miR-9 and miR-181 have
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recently been reported to repress Lin28 expression (33,34)
in a fashion similar to let-7. It remains to be clariﬁed
whether precursors of miR-9 and miR-181 bind to Lin28
in cells.
HnRNP A1 is a nucleocytoplasmic shuttling protein
known for its various roles in RNA biology. It carries
two copies of an RNA recognition motif (RRM) at the
N-terminus and a glycine-rich domain at the C-terminus,
which is responsible for cooperative binding to RNAs.
hnRNP A1 also regulates Drosha processing of two
miRNAs. The protein binds to pri-miR-18a, a member of
the polycistronic miR-17-92 cluster (14), alters the struc-
ture of pri-miR-18a and facilitates Drosha cleavage
without affecting neighbouring hairpins in the cluster.
hnRNPA1 also binds to pri-let-7a-1 and acts as a repressor
of let-7 biogenesis by antagonizing the docking of KSRP
(15) (KH-type splicing regulatory protein), which is a com-
ponent of Drosha and Dicer complexes and known to posi-
tively regulate processing of many miRNAs (16).
The human let-7 family has 10 mature miRNAs
expressed from 13 distinct precursors (35). We reasoned
that a simple binding screen could reveal additional
hnRNP A1-regulated candidates of the let-7 precursors
and other pre-miRNAs. We screened hnRNP A1 in its
native form directly from Hela cell lysates using a
speciﬁc antibody for detection. This antibody is speciﬁc
for hnRNP A1 (27), (cf. also Supplementary Figure S1)
and allowed facile detection of the protein in Hela cell
lysates in this assay (Supplementary Figure S2B).
Roughly one-fourth of the immobilized pre-miRNAs
captured hnRNP A1 (Figure 2C). Strikingly, except for
pre-let-7i, all let-7 members generated high signals.
To validate these results, we reversed the format of the
assay and coated the surface with UP1, a fragment of
hnRNP A1 that contains the RRM domains
(Figure 2D). Once again, the binding proﬁle from a
screen of the biotinylated pre-miRNAs was similar to
that of the native protein from cellular lysates, indicating
that the RRMs accounted for the majority of the RNA
interactions seen in this assay.
Interactions of hnRNP A1 with let-7 precursors in cells
For assessing whether the interactions also occurred with
endogenously expressed hnRNP A1 and miRNAs, we
immunoprecipitated hnRNP A1 with antibodies from
Figure 1. Schematics of the three conﬁgurations used in the microtiter plate assays of this communication. (A) Binding assay with direct coating of
puriﬁed RBPs (e.g. recombinant protein domains). (B) Binding assay with streptavidin immobilized pre-miRNAs and detection of RBP by
antibodies. Source of RBP can be total cell lysate. (C) Inhibition assay for determining afﬁnities of interactions. The assay is similar to that
depicted in (B); the biotinylated RNA can be a short oligoribonucleotide known to bind the RBP.
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Figure 2. Recognition of pre-miRNAs by native and recombinant RBPs in microtiter plate screening assays (A–D). The proteins assayed were as
follows: (A) recombinant puriﬁed ZnF domains of Lin28 [data from a subset of the library has been presented earlier (29)]; (B) Lin28 in lysates of
Myc-tagged Lin28-transfected HEK293T cells; (C) hnRNP A1 in lysates of Hela cells; (D) recombinant puriﬁed UP1 (a fragment of hnRNP A1
containing two RRM domains). Figures are representative of multiple experiments. Labels in brackets indicate signals observed in one experiment
only. Error bars represent standard deviations. The labels on the X-axis of panels (A) and (C) are aligned with those of (B) and (D), respectively. The
background is expressed as ratio between the average of the ﬁve lowest values in the assay and the maximal value on the plate, and it was 12.7, 7.3,
0.02 and 0.55% for screens A–D, respectively. (E) RNA-immunoprecipitation analysis of miRNA precursors associated with hnRNP A1 in Hela
cells. Lysed Hela cells were incubated with anti-hnRNPA1 or control antibody coated magnetic beads. Precursor miRNAs were quantiﬁed by
qRT-PCR with primers covering the pre-miRNA sequences. Averages of the cycle thresholds (Ct) from three independent biological replicates with
standard deviations are shown. Asterisks denote statistical signiﬁcance (two-tailed Student’s t-test) at P< 0.05 (*) and at P< 0.01 (**).
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Hela cell extracts and measured the associated RNA
species by qRT-PCR (Figure 2E). The primers used
detected pre-miRNAs but may also recognize the respect-
ive pri-miRNAs. The enrichment factors (hnRNPA1
associated/control) spanned a range of 2-fold for let-7a-1
and let-7f-2 to levels up to 45-fold for let-7f-1 and let-7i.
No enrichment was seen for the precursors of miR-107,
which had been negative in the screening assays.
Afﬁnity of hnRNP A1 against pre-miRNAs
We estimated the dissociation constants for hnRNP
A1 with the let-7 family members and additional pre-
miRNAs by an inhibition assay, again based on RNA
ELISA using captured protein as the readout (Figure 3).
Importantly, the inhibition assay also served to show that
the signals from the screen (Figure 2C) were owing to
speciﬁc interactions between hnRNP A1 and the respect-
ive pre-miRNAs. In a pre-incubation step, we allowed
graded concentrations of non-labelled pre-miRNAs to
equilibrate with a constant dilution of cell lysate and, in
the next step, placed these mixtures in wells that contained
an immobilized biotinylated version of the SELEX winner
sequence of hnRNP A1 (22). The assay was designed to
measure a fraction of the free protein in the solution.
Under the assumption that the equilibrium was not
greatly disturbed during the time in the coated wells, we
calculated IC50-values, which corresponded to the dissoci-
ation constants (Kd). For the SELEX winner sequence,
we determined a Kd of 8 nM in a buffer containing
250mM NaCl. This value is roughly in agreement with
Figure 3. Determination of afﬁnities of pre-miRNAs to hnRNP A1. (A) Inhibition curves for pre-miRNAs and a consensus sequence for hnRNP A1
[SELEX winner sequence (22)]. Source of hnRNP A1 was a lysate of Hela cells; pre-miRNAs were chemically re-synthesized. In this two-step assay,
equilibrated mixtures of a constant lysate dilution and varying oligoribonucleotide concentrations were transferred to wells coated with biotinylated
winner sequence for capturing a fraction of the non-occupied hnRNP A1. Following antibody mediated ampliﬁcation and background subtraction,
the signals were normalized to the non-inhibited control. Error bars indicate standard deviations of duplicates. Inset: scheme of the inhibition assay.
The table shows Kd values derived from the binding curves.
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the reported Kd of 1 nM from a ﬁlter binding assay with
radiolabelled RNA (22) (in a buffer of 100mM KCl,
2.5mM MgCl2) and a ﬂuorescence assay with a value
of 2.5 nM (36). The Kd values correlated with the
binding strength observed in the screening assay (cf.
Supplementary Figure S3). Pre-let-7i, which had scored
negative and low in the screening assays (Figure 2C and
D, respectively), displayed a measurable, but lowest
ranking afﬁnity within the pre-let-7 family. A small
number of imperfections to the correlation across a large
panel of 95 pre-miRNAs can be expected, especially with
measurements under one set of conditions, and may arise
for many reasons, including assay inherent imprecision
and differences between binding to immobilized reagents
compared with binding in solution. However, in a sensi-
tive assay, such as the one of Figure 2D, even low signals
seem to be meaningful.
In our assay, the afﬁnities of the pre-let-7 family
members spanned a range of 12–43 nM. The value for
pre-let-7a-1, for which hnRNP A1 has been shown to
inhibit Drosha processing by displacing KSRP, was
17 nM. Pre-miR-18a, whose processing from the pri- to
the pre-form by Drosha is enhanced by hnRNP A1 (14),
displayed a distinctly lower afﬁnity of 119 nM. Possibly,
the requirements for enhanced processing, where hnRNP
A1 acts as an auxiliary factor for Drosha, differ from
those of a merely inhibitory function.
The new observation that hnRNP A1 binds to many
let-7 precursors suggests that this protein may not only
displace KSRP from let-7a-1 but also from other let-7
precursors. Compared with hnRNP A1, Lin28 bound
the let-7 precursors with considerably higher afﬁnity
(0.15–0.46 nM) under similar conditions (29). The
screening results, together with the inhibition assay and
the immunoprecipitation data, conﬁrm the functionality
of hnRNP A1-binding motifs on let-7 loop regions
postulated earlier (15). In two unrelated screens of an
RRM protein (to be described elsewhere), little or no
binding to let-7 family members was observed,
demonstrating that the screen was not biased towards
this family.
KSRP binds prominently to pre-miR-1
In a ﬁnal example, we demonstrate the activity of KSRP
in the binding screen. By western blot analysis of Hela cell
lysates, the antibody proved to be speciﬁc for KSRP
(Supplementary Figure S1). The screening proﬁle
(Figure 4) showed a prominent signal for pre-miR-1-2
(supported by testing at various lysate dilutions, cf.
Supplementary Figure S2C) and weaker signals for
various other pre-miRNAs, including pre-let-7 members.
KSRP binds strongly to precursors of the muscle-speciﬁc
miR-1 and supports their maturation (16). A strict correl-
ation between KSRP’s function in the Dicer complex and
its RNA binding is not expected. Still, the results of the
screen support the notion of widespread, but mostly
moderate augmentation of miRNA processing. Owing
to its four KH domains with individually low afﬁnity,
the binding preferences of KSRP have been difﬁcult to
rationalize (37).
DISCUSSION
Currently, one of the major challenges in the non-coding
RNA ﬁeld is the elucidation of the pathways and
mechanisms that regulate miRNA biogenesis. Key to
this endeavour is the identiﬁcation of the involved
factors. Not surprisingly, the post-transcriptionally
acting RBPs have turned out to play a central role in
miRNA biogenesis. For a given RBP, unbiased genome-
wide methods based on RNA immunoprecipitation and
cross-linking such as PAR-CLIP (38) strive for a com-
prehensive picture for all of the coding and non-coding
RNA species bound by the RBP in a selected cell type.
They provide a snapshot of the interacting RNA species in
a cell and also allow to identify the RNA elements
recognized by RBPs. Identiﬁcation of bound RNAs is
performed after a multi-step protocol in which the RNA
sample is converted for high-throughput sequencing.
Sequence reads are subsequently sifted bioinformatically
to identify interacting RNAs. A detailed mechanistic
understanding of an RBP’s activity, as well as its
Figure 4. Binding of KSRP in lysates of Hela cells to immobilized pre-miRNAs. The schematics depict the assay conﬁguration used for the assay.
Speciﬁcity for KSRP was accomplished by an antibody against the protein. One of two experiments is shown. Error bars represent standard
deviations. The background, expressed as ratio between the average of the ﬁve lowest values in the assay and the maximal value on the plate,
was 7.5%.
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speciﬁcity and afﬁnity, then calls for structural and
biochemical studies with the protein and its RNA
partner molecules (39). In contrast to genome-wide
methods, the in vitro approach of screening synthetic
pre-miRNAs presented here is a system that gauges
quantitatively the potential of an RBP to bind to a
deﬁned set of miRNA precursor structures in cells where
both components are expressed. As this in vitro system is
dissociated from the requirement of co-expression,
binding of KSRP to the muscle speciﬁc pre-miR-1-2, for
example, was detectable in our experiments without prior
selection of the cellular system. As long as binding sites in
the microtiter plates are not saturated by other RBPs, the
system has the potential to detect interactions with
proteins expressed with a wide range of abundances, if
the sensitivity of the antibody allows. Mindful of the
potential to detect transient non-functional interactions
(40), a positive result implies a corresponding binding
interaction in vivo and an ensuing biological effect. Our
observations with the binding of Lin28 to let-7 pre-
miRNAs and the interaction of KSRP with pre-miR-1-2,
where the biological roles of the RBPs in miRNA
biogenesis are well documented, support this concept.
An enabling aspect of our methodology is the chemical
synthesis of libraries of unmodiﬁed and biotinylated pre-
miRNAs. Once the collection of biotinylated pre-miRNAs
is assembled, binding assays to several RBPs are quickly
done and evaluated. Although the chemical synthesis of
long RNAs is unable to compete in terms of yields and
lengths with in vitro transcription from DNA templates, it
has the advantage of allowing site-speciﬁc incorporation
of functionalized nucleosides, i.e. biotin, at any desired
position. Converting in vitro-transcribed RNA molecules
to deﬁned biotinylated derivatives requires considerable
additional handling.
The importance of determining interaction parameters
between biomacromolecules has triggered the development
of numerous analytical methods. These range from
qualitative binding tests to quantitative, biophysically
rigorous methods such as ﬂuorescence polarization and
isothermal calorimetry that do not require separation of
bound from free components. Traditionally, RNA–
protein interaction studies entail radiolabelled RNAs and
puriﬁed proteins, often in conjunction with gel shift or ﬁlter
binding to separate bound from excess ligands. Here, we
introduce related types of chemiluminescent assays that,
for two versions, do not require puriﬁed RBPs nor
radiolabelled components. One assay version is suitable
for screening RNA–protein interactions and the second
for deriving afﬁnities. Basically, speciﬁcity for the binding
protein, even in crude lysates, is achieved by an antibody
speciﬁc for the protein or for a tag, if expressed in
appropriate plasmids. Highly practical aspects are the
ease with which assay conﬁgurations or conditions can be
changed, avoidance of radioactivity and the use of the
protein component for the readout. The assays with
directly adsorbed recombinant proteins are technically
simple and modest with respect to amounts of reagents
required.
In contrast to measurements with recombinant proteins,
cell lysates as a source of RBP allow probing proteins in
native form, an important aspect for large or sensitive
proteins and protein complexes. This type of assay also
permits easily determining binding activity of an RBP
from modiﬁed or drug-treated cells. We believe that the
inhibition version of the assay may replace gel shift assays
in many instances where RNA–protein interactions are
studied and should also be suitable for testing compounds
in vitro. The use of small assay volumes, as here in
microtiter plates, implies that the study of RNA–protein
interactions can be easily extended to a wider, possibly
genomic, scale.
In this study, we screened a set of 95 pre-miRNAs
in two conﬁgurations, one based on adsorbed puriﬁed
recombinant protein domains and the other on immobil-
ized miRNA precursors. For Lin28, we observed a sharper
discrimination of binders with directly adsorbed proteins
compared with the inverse, protein capturing assay with
cell lysates. Obviously, differences can arise from the lack
of RNA interaction domains, as the recombinant protein
consisted of the Lin28 ZnF domains without the CSD. Less
tractable differences may be owing to denaturing of
proteins when directly adsorbed to surfaces and other
surface phenomena. Still, both screening formats identiﬁed
the let-7 family precursors in the Lin28 screen. In our
second example where we compared full-length protein
and a recombinant domain, the binding proﬁles of
hnRNP A1 to pre-miRNAs were practically identical.
The screen, together with the inhibition assay and
supported by the RNA-immunoprecipitation experiments,
revealed for the ﬁrst time that hnRNP A1 interacts with
many members of the let-7 family. The results conﬁrm the
functionality of hnRNP A1-binding motifs on let-7 loop
regions postulated earlier (15). The afﬁnities of a subset of
pre-miRNAs measured by inhibition assay were roughly
consistent with the signal intensities of the plate-binding
screen. As these afﬁnities were similar to those of pre-let-
7a-1, on which hnRNP A1 is effective as a processing
inhibitor, experimental testing of the hnRNP A1 effect
on the other pre-let-7 members could be envisaged. It is
clear that binding strength alone cannot explain or
predict biological outcomes. Pre-miR-18a bound
relatively poorly to hnRNP A1 in both the screening and
inhibition assays. Possibly, the known cleavage-induced
conformation changes reduce the afﬁnity of hnRNP
A1 to the pre-miRNA as compared with the primary
transcript, which was found in co-precipitates with
hnRNP A1 (14).
A variety of investigations of RBPs using these
techniques is currently ongoing.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–2 and Supplementary Figures
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